Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/18/47/ed/1847ed37-2fcd-fd8b-9e9f-279520d38102/mza_16492176921634049539.jpg/600x600bb.jpg
Global Health Conversations
Christiana
35 episodes
9 months ago
Read the newsletter here: Are we living in an age of outbreaks?This is the last holiday season newsletter podcast episode! If you listened to them, I hope you enjoyed them ! :) If you enjoyed this, I invite you to subscribe to the fortnightly newsletter here: https://globalhealthconversations.substack.com/ The next edition will be Sunday 4th January 2025. And if you enjoy the GHC podcast, please leave me a little 5 star rating wherever you listen. :) It means a lot. Finally, I have been ...
Show more...
Medicine
Society & Culture,
Health & Fitness,
Science
RSS
All content for Global Health Conversations is the property of Christiana and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Read the newsletter here: Are we living in an age of outbreaks?This is the last holiday season newsletter podcast episode! If you listened to them, I hope you enjoyed them ! :) If you enjoyed this, I invite you to subscribe to the fortnightly newsletter here: https://globalhealthconversations.substack.com/ The next edition will be Sunday 4th January 2025. And if you enjoy the GHC podcast, please leave me a little 5 star rating wherever you listen. :) It means a lot. Finally, I have been ...
Show more...
Medicine
Society & Culture,
Health & Fitness,
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/18/47/ed/1847ed37-2fcd-fd8b-9e9f-279520d38102/mza_16492176921634049539.jpg/600x600bb.jpg
#20: The Profitability of Skinny - How Semaglutides made Novo Nordisk Europe's most profitable company
Global Health Conversations
25 minutes
1 year ago
#20: The Profitability of Skinny - How Semaglutides made Novo Nordisk Europe's most profitable company
In this episode, we explore the economics of thinness and the phenomenal rise of GLP-1 receptor agonists in the weight loss market. Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, has become Europe's most profitable company, surpassing even the luxury giant LVMH. We delve into the social and economic capital associated with thinness, examining how societal attitudes toward body image drive the profitability of weight loss drugs.We also break down the science behind ...
Global Health Conversations
Read the newsletter here: Are we living in an age of outbreaks?This is the last holiday season newsletter podcast episode! If you listened to them, I hope you enjoyed them ! :) If you enjoyed this, I invite you to subscribe to the fortnightly newsletter here: https://globalhealthconversations.substack.com/ The next edition will be Sunday 4th January 2025. And if you enjoy the GHC podcast, please leave me a little 5 star rating wherever you listen. :) It means a lot. Finally, I have been ...